Table 3 Correlation between PR-LncRNA and clinical characteristics in the glioma cohort.
From: PR-LncRNA signature regulates glioma cell activity through expression of SOX factors
Clinical/pathological characteristics | Total cases | # | PR-LncRNA Expression | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
PR-LncRNA 1 | PR-LncRNA 5 | PR-LncRNA 10 | |||||||||
High | Low | P Value | High | Low | P Value | High | Low | P Value | |||
Sex | |||||||||||
Male | 43 | 22 | 15 | 6 | ns | 13 | 8 | 0.05* | 14 | 7 | ns |
Female | 21 | 20 | 2 | 19 | 3 | 19 | 3 | ||||
Age, years | |||||||||||
>65 | 43 | 13 | 11 | 2 | ns | 10 | 3 | ns | 10 | 3 | ns |
<65 | 30 | 24 | 6 | 21 | 9 | 23 | 7 | ||||
Localization | |||||||||||
Frontal | 20 | 14 | 6 | ns | 12 | 8 | 0.04* | 20 | 8 | 0.019* | |
Temporal | 18 | 17 | 1 | ns | 16 | 2 | ns | 17 | 1 | 0.021* | |
Parietal | 6 | 4 | 2 | ns | 3 | 3 | ns | 4 | 2 | ns | |
Other | 10 | 10 | 0 | ns | 10 | 0 | 0.034* | 10 | 0 | 0.048* | |
Multifoci | 5 | 4 | 1 | ns | 4 | 1 | ns | 5 | 0 | ns | |
Right | 23 | 19 | 4 | ns | 16 | 7 | ns | 17 | 6 | ns | |
Left | 17 | 14 | 3 | ns | 14 | 3 | ns | 14 | 3 | ns | |
Bilateral | 3 | 2 | 1 | ns | 2 | 1 | ns | 2 | 1 | ns | |
Eloquent | 11 | 9 | 2 | ns | 8 | 3 | ns | 8 | 3 | ns | |
Ventricular contact | 18 | 16 | 2 | ns | 16 | 2 | 0.065* | 16 | 2 | ns | |
Radiological Characteristics | |||||||||||
Volume | |||||||||||
>50 | 43 | 24 | 19 | 5 | ns | 17 | 7 | ns | 17 | 7 | ns |
<50 | 19 | 16 | 3 | 15 | 4 | 16 | 3 | ||||
Perfusion | |||||||||||
>6 | 39 | 24 | 19 | 5 | ns | 17 | 7 | ns | 17 | 7 | ns |
<6 | 15 | 12 | 3 | 11 | 4 | 12 | 3 | ||||
Karnofsky score | |||||||||||
>70 | 43 | 35 | 27 | 8 | ns | 24 | 11 | ns | 26 | 9 | ns |
<70 | 8 | 8 | 0 | 8 | 0 | 7 | 1 | ||||
Resection | |||||||||||
Total | 43 | 29 | 23 | 6 | ns | 21 | 8 | ns | 22 | 7 | ns |
Subtotal | 14 | 12 | 2 | 11 | 3 | 11 | 3 | ||||
